1zn3: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
|PDB= 1zn3 |SIZE=350|CAPTION= <scene name='initialview01'>1zn3</scene>, resolution 2.60Å | |PDB= 1zn3 |SIZE=350|CAPTION= <scene name='initialview01'>1zn3</scene>, resolution 2.60Å | ||
|SITE= | |SITE= | ||
|LIGAND= <scene name='pdbligand= | |LIGAND= <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> | ||
|ACTIVITY= [http://en.wikipedia.org/wiki/Bontoxilysin Bontoxilysin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.69 3.4.24.69] | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Bontoxilysin Bontoxilysin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.69 3.4.24.69] </span> | ||
|GENE= | |GENE= | ||
|DOMAIN= | |||
|RELATEDENTRY=[[1t3a|1T3A]], [[1t3c|1T3C]], [[1zkw|1ZKW]], [[1zkx|1ZKX]], [[1zl5|1ZL5]], [[1zl6|1ZL6]] | |||
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1zn3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1zn3 OCA], [http://www.ebi.ac.uk/pdbsum/1zn3 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1zn3 RCSB]</span> | |||
}} | }} | ||
Line 26: | Line 29: | ||
[[Category: Binz, T.]] | [[Category: Binz, T.]] | ||
[[Category: Swaminathan, S.]] | [[Category: Swaminathan, S.]] | ||
[[Category: botulinum neurotoxin e]] | [[Category: botulinum neurotoxin e]] | ||
[[Category: catalytic domain]] | [[Category: catalytic domain]] | ||
Line 33: | Line 34: | ||
[[Category: light chain]] | [[Category: light chain]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 01:39:03 2008'' |
Revision as of 01:39, 31 March 2008
| |||||||
, resolution 2.60Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | , | ||||||
Activity: | Bontoxilysin, with EC number 3.4.24.69 | ||||||
Related: | 1T3A, 1T3C, 1ZKW, 1ZKX, 1ZL5, 1ZL6
| ||||||
Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
Coordinates: | save as pdb, mmCIF, xml |
Crystal structure of Glu335Ala mutant of Clostridium botulinum neurotoxin type E
OverviewOverview
Clostridial neurotoxins comprising the seven serotypes of botulinum neurotoxins and tetanus neurotoxin are the most potent toxins known to humans. Their potency coupled with their specificity and selectivity underscores the importance in understanding their mechanism of action in order to develop a strategy for designing counter measures against them. To develop an effective vaccine against the toxin, it is imperative to achieve an inactive form of the protein which preserves the overall conformation and immunogenicity. Inactive mutants can be achieved either by targeting active site residues or by modifying the surface charges farther away from the active site. The latter affects the long-range forces such as electrostatic potentials in a subtle way without disturbing the structural integrity of the toxin causing some drastic changes in the activity/environment. Here we report structural and biochemical analysis on several mutations on Clostridium botulinum neurotoxin type E light chain with at least two producing dramatic effects: Glu335Gln causes the toxin to transform into a persistent apoenzyme devoid of zinc, and Tyr350Ala has no hydrolytic activity. The structural analysis of several mutants has led to a better understanding of the catalytic mechanism of this family of proteins. The residues forming the S1' subsite have been identified by comparing this structure with a thermolysin-inhibitor complex structure.
About this StructureAbout this Structure
1ZN3 is a Single protein structure of sequence from Clostridium botulinum. Full crystallographic information is available from OCA.
ReferenceReference
Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzyme., Agarwal R, Binz T, Swaminathan S, Biochemistry. 2005 Jun 14;44(23):8291-302. PMID:15938619
Page seeded by OCA on Mon Mar 31 01:39:03 2008